Claudia FreyJan18R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisseby Claudia Frey | January 18, 202281Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) [2] at the ... Read more > Press ReleaseCorporateFluidFM ApplicationsJan 18, 2022
Claudia FreyMar24Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeksby Claudia Frey | March 24, 2021497Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation [2] , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 24, 2021
Claudia FreyMay04Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editingby Claudia Frey | May 4, 2020754Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University [1] and Cytosurge AG [2] , a company manufacturing unique high-precision ... Read more > Press ReleaseCorporateFluidFM ApplicationsMay 4, 2020
Claudia FreyJul14FluidFM single cell extractionby Claudia Frey | July 14, 2016293Zurich | A groundbreaking new method for single cell analysis based on FluidFM® technology allows scientist to investigate the behavior of individual cells within their natural environment. The new me... Read more > Press ReleaseCorporateFluidFM ApplicationsJul 14, 2016
